A new bacterial strain that can cause the flu has been found in soil samples collected by researchers from across the globe.
The researchers at the University of Alberta say they discovered the strain by sequencing soil samples from across Canada.
The strain was initially identified in a soil sample taken in 2013 and has since been identified in soil from more than 40 countries, including the United States, Australia, and France.
The new strain, named B. bovid, was isolated from soil samples that were collected at a farm in Quebec and the University at Buffalo, New York.
Researchers found that the bacteria was able to enter soil and convert to a new type of Endocytic strain that could be resistant to antibiotics.
The research is the first to show the effectiveness of the new strain and is published online today in Nature Communications.
B.bovid is a novel strain of Endotoxin B (EB), which is responsible for the symptoms of the flu.
The EB strain is resistant to the antibiotics ciprofloxacin and ciprolizumab, and can survive for several days in the absence of oxygen, making it a viable host for bacteria.
However, researchers say they were not able to identify the specific strain of EB that was responsible for producing the new flu strain.
Bovid has also been found to cause other serious illness, including respiratory distress, severe liver failure, and brain damage.
The University of Toronto, the University College London, and University of California, Berkeley were among the universities involved in the research.
The scientists say that B.covid was found in the soil at the site of the farm where the research was conducted, but they could not identify the exact location because of a lack of a microscope.
The team says the research is important because it shows that the new variant of EB is not as dangerous as previously believed, and is more effective than previously thought at fighting the flu in humans.
The bacteria was isolated in soil at a Saskatchewan farm that has produced B.a.b. since 2012, the researchers say.
The university’s Dr. Robert Pappas, who conducted the research, says the results have been very encouraging and that the research shows that we have to continue to monitor these new strains of EB.
He says the bacteria is more likely to make the strain that was found to be resistant.
Pappa says the B.bcovid strain is very resistant to ciproprazole, a drug that has been used to treat EB.
Poppa says this is a good sign because if we can get B.bbovid to make this new variant, it could help treat people with a very severe form of EB, such as people with kidney stones.
He adds that this could mean the new B.bsb strain will have a larger potential to spread and cause a pandemic, if it can be isolated from a larger number of people.
“There is hope that this new strain could be used in combination with ciprotrexa, which has already been used in many cases to treat the disease,” he says.
“The cipretex drug is very powerful, but it only works if the patient is already infected, so the patient would need to be infected with EB before the drug would work.”
The researchers say that the B-bovids ability to survive and thrive in the environment has implications for the environment as a whole.
“It’s important to note that the strain of bacteria we found here in Saskatchewan is not a new strain,” Pappamas says.
Pappa says the new strains B.ebb and B.abb are likely to be more common in the future.
“I think we’re just at the beginning of what’s to come, and we need to take this time to see if we’re going to be able to find other strains that can survive in our environment, and how we can keep them out of the environment.”
The research was supported by the Canadian Institutes of Health Research (CIHR), Canada Science and Engineering Research Council, the Canada Research Chairs Program, and the Canada Excellence Research Channels program.
